NYSE:BSX

Boston Scientific Stock News

etoro logo Buy BSX
*Your capital is at risk
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
Company to begin limited market release in Europe in June MARLBOROUGH, Mass., May 25, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the E

Big call buying in Boston Scientific

01:55pm, Monday, 24'th May 2021
"Halftime Report" trader Pete Najarian spots unusual activity in the options market
MARLBOROUGH, Mass., May 24, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 37th Annual Strategic Decisions Conference on Friday, June 4, 2021.
MARLBOROUGH, Mass., May 18, 2021 /PRNewswire/ -- Data presented at hotline and late-breaking trial sessions today at the EuroPCR 2021 congress demonstrated positive procedural performance, including

What's New With Boston Scientific Stock?

07:30am, Monday, 17'th May 2021
The stock price of Boston Scientific has corrected 3.5% over the last five trading sessions, and the dip appears to be a good buying opportunity in our view. Not only did the company post an upbeat pe
Like most medical device manufacturers, Boston Scientific Corp. ( BSX , Financial) also witnessed a slowdown in 2020 on account of the lower demand for medical devices and the deferral of elective sur
Rebound in base sales make us optimistic about OMI, INGN, XRAY and CNTG's results this time around.
MARLBOROUGH, Mass., (May 3, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.
Rapid innovation is boosting the robotic surgery space, putting the spotlight on Johnson & Johnson (JNJ), Stryker (SYK), Boston Scientific (BSX), Intuitive Surgical (ISRG) and Asensus Surgical (ASXC).
"Halftime Report" trader Pete Najarian spots unusual activity in the options market
Boston Scientific Corporation (NYSE: BSX) Q1 sales grew by 5.9% (organically) to $2.75 billion, beating the previous guidance range between negative 3% and 3% in the quarter, better than the con
Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q1 2021 Results - Earnings Call Transcript
Boston Scientific (BSX) registers strong sequential improvement in overall financial performance in Q1.
Boston Scientific (BSX) delivered earnings and revenue surprises of 23.33% and 5.30%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.752 billion during the first quarter of 2021.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE